Nothing Special   »   [go: up one dir, main page]

DK3619199T3 - Fremstilling af 2-([1,2,3]triazol-2-yl)-benzoesyrederivater - Google Patents

Fremstilling af 2-([1,2,3]triazol-2-yl)-benzoesyrederivater Download PDF

Info

Publication number
DK3619199T3
DK3619199T3 DK18722948.9T DK18722948T DK3619199T3 DK 3619199 T3 DK3619199 T3 DK 3619199T3 DK 18722948 T DK18722948 T DK 18722948T DK 3619199 T3 DK3619199 T3 DK 3619199T3
Authority
DK
Denmark
Prior art keywords
triazol
preparation
benzoic acid
acid derivatives
derivatives
Prior art date
Application number
DK18722948.9T
Other languages
English (en)
Inventor
Patric Dörrwächter
Gunther Schmidt
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Application granted granted Critical
Publication of DK3619199T3 publication Critical patent/DK3619199T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/061,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/70Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
    • B01J23/72Copper
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK18722948.9T 2017-05-03 2018-05-02 Fremstilling af 2-([1,2,3]triazol-2-yl)-benzoesyrederivater DK3619199T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2017060451 2017-05-03
PCT/EP2018/061172 WO2018202689A1 (en) 2017-05-03 2018-05-02 Preparation of 2-([1,2,3]triazol-2-yl)-benzoic acid derivatives

Publications (1)

Publication Number Publication Date
DK3619199T3 true DK3619199T3 (da) 2021-09-27

Family

ID=62116854

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18722948.9T DK3619199T3 (da) 2017-05-03 2018-05-02 Fremstilling af 2-([1,2,3]triazol-2-yl)-benzoesyrederivater

Country Status (20)

Country Link
US (1) US11124488B2 (da)
EP (1) EP3619199B1 (da)
JP (1) JP7182562B2 (da)
KR (1) KR102582197B1 (da)
CN (1) CN110612291B (da)
CA (1) CA3059394C (da)
CY (1) CY1124777T1 (da)
DK (1) DK3619199T3 (da)
ES (1) ES2892161T3 (da)
HR (1) HRP20211304T1 (da)
HU (1) HUE055904T2 (da)
IL (1) IL270274B (da)
LT (1) LT3619199T (da)
MX (1) MX2019012902A (da)
PL (1) PL3619199T3 (da)
PT (1) PT3619199T (da)
RS (1) RS62357B1 (da)
SI (1) SI3619199T1 (da)
TW (1) TWI756418B (da)
WO (1) WO2018202689A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115427037A (zh) 2020-04-19 2022-12-02 爱杜西亚药品有限公司 达立克生(daridorexant)的医药用途
AR129309A1 (es) 2022-05-13 2024-08-07 Idorsia Pharmaceuticals Ltd Derivados de hidrazina-n-carboxamida cíclica sustituida con tiazoloaril-metilo
CN118724879B (zh) * 2023-12-19 2025-02-11 南京知和医药科技有限公司 一种氘代稠环化合物及其制备方法与用途

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602007012910D1 (de) 2006-08-15 2011-04-14 Actelion Pharmaceuticals Ltd Azetidinverbindungen als orexin-rezeptor-antagonisten
ES2350460T3 (es) 2006-09-29 2011-01-24 Actelion Pharmaceuticals Ltd. Derivados de 3-aza-biciclo[3.1.0]hexano.
PE20081229A1 (es) 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
CL2007003827A1 (es) 2006-12-28 2008-09-26 Actelion Pharmaceuticals Ltd Compuestos derivados de n-(2-aza-biciclo(3.1.0)hex-3-ilmetil)amida; y su uso para prevenir o tratar la depresion, neurosis, esquizofrenia, ansiedad, adicciones, epilepsia, dolor, enfermedades cardiacas, entre otras.
ATE483707T1 (de) 2007-05-14 2010-10-15 Actelion Pharmaceuticals Ltd 2-cyclopropylthiazolderivate
AU2008260647A1 (en) 2007-05-23 2008-12-11 Merck Sharp & Dohme Corp. Cyclopropyl pyrrolidine orexin receptor antagonists
WO2011050200A1 (en) 2009-10-23 2011-04-28 Janssen Pharmaceutica Nv Fused heterocyclic compounds as orexin receptor modulators
WO2011050202A1 (en) 2009-10-23 2011-04-28 Janssen Pharmaceutica Nv Fused heterocyclic compounds as orexin receptor modulators
SI3093291T1 (sl) 2009-10-23 2019-08-30 Janssen Pharmaceutica Nv Disubstituirani oktahidropirolo (3,4-C)piroli, kot modulatorji receptorja oreksina
MX2013006715A (es) 2010-12-17 2013-08-26 Taisho Pharmaceutical Co Ltd Derivado de pirazol.
WO2012085852A1 (en) 2010-12-22 2012-06-28 Actelion Pharmaceuticals Ltd 3,8-diaza-bicyclo[4.2.0]oct-8-yl amides
EP2680697B1 (en) 2011-03-03 2018-01-10 Merck Sharp & Dohme Corp. Process for the preparation of an orexin receptor antagonist
WO2012145581A1 (en) 2011-04-20 2012-10-26 Janssen Pharmaceutica Nv Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
EP2730573A4 (en) 2011-07-05 2014-12-03 Taisho Pharmaceutical Co Ltd METHYLPIPERIDINDERIVAT
WO2013050938A1 (en) * 2011-10-04 2013-04-11 Actelion Pharmaceuticals Ltd 3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives
PL2776430T3 (pl) 2011-11-08 2016-09-30 Pochodne 2-(1,2,3-triazol-2-ilo)benzamidu i 3-(1,2,3-triazol-2-ilo)pikolinoamidu jako antagoniści receptora oreksynowego
EP2847343A4 (en) 2012-05-09 2016-04-06 Merck Sharp & Dohme METHOD FOR PRODUCING A INTERMEDIATE PRODUCT FOR AN OREXINE RECEPTOR ANTAGONIST
WO2013182972A1 (en) 2012-06-04 2013-12-12 Actelion Pharmaceuticals Ltd Benzimidazole-proline derivatives
JP2014015452A (ja) 2012-06-15 2014-01-30 Taisho Pharmaceutical Co Ltd ピラゾール誘導体を含有する医薬
EP2906553B1 (en) 2012-10-10 2019-06-26 Idorsia Pharmaceuticals Ltd Orexin receptor antagonists which are [ortho bi (hetero )aryl]-[2-(meta bi (hetero)aryl)-pyrrolidin-1-yl]-methanone derivatives
US9403813B2 (en) 2013-03-12 2016-08-02 Actelion Pharmaceuticals Ltd. Azetidine amide derivatives as orexin receptor antagonists
TW201444821A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代之哌啶化合物及其作為食慾素受體調節劑之用途
TW201444849A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
UA119151C2 (uk) 2013-12-03 2019-05-10 Ідорсія Фармасьютікалз Лтд КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА
PT3077389T (pt) 2013-12-03 2017-12-15 Idorsia Pharmaceuticals Ltd Forma cristalina de (s)-(2-(6-cloro-7-metil-1hbenzo[d]imidazol-2-il)-2-metilpirrolidin-1-il)(5-metoxi-2-(2h-1,2,3-triazol-2-il)fenil)metanona e a sua utilização como como antagonistas do receptor de orexina
TR201815342T4 (tr) 2013-12-04 2018-11-21 Idorsia Pharmaceuticals Ltd Benzimidazol-prolin türevlerinin kullanımı.
TW201613891A (en) 2014-02-12 2016-04-16 Eolas Therapeutics Inc Substituted prolines / piperidines as orexin receptor antagonists
WO2016020403A1 (en) 2014-08-04 2016-02-11 Sandoz Ag Preparation of a benzoic acid derivative and its use for the preparation of suvorexant
CN104649983B (zh) 2014-12-23 2018-01-23 广东东阳光药业有限公司 一种酸的制备方法
WO2016171248A1 (ja) 2015-04-24 2016-10-27 武田薬品工業株式会社 複素環化合物

Also Published As

Publication number Publication date
TW201843144A (zh) 2018-12-16
KR102582197B1 (ko) 2023-09-22
HUE055904T2 (hu) 2021-12-28
IL270274A (da) 2019-12-31
HRP20211304T1 (hr) 2021-11-12
US20210114997A1 (en) 2021-04-22
TWI756418B (zh) 2022-03-01
RS62357B1 (sr) 2021-10-29
US11124488B2 (en) 2021-09-21
PT3619199T (pt) 2021-10-01
KR20200003097A (ko) 2020-01-08
MX2019012902A (es) 2019-12-16
CY1124777T1 (el) 2022-11-25
CA3059394A1 (en) 2018-11-08
SI3619199T1 (sl) 2021-11-30
JP2020518573A (ja) 2020-06-25
CN110612291B (zh) 2024-02-13
LT3619199T (lt) 2021-09-27
WO2018202689A1 (en) 2018-11-08
IL270274B (en) 2022-08-01
JP7182562B2 (ja) 2022-12-02
CN110612291A (zh) 2019-12-24
PL3619199T3 (pl) 2021-12-20
EP3619199A1 (en) 2020-03-11
ES2892161T3 (es) 2022-02-02
EP3619199B1 (en) 2021-07-07
CA3059394C (en) 2023-09-12

Similar Documents

Publication Publication Date Title
MA47125A (fr) Dérivés de pyrazole en tant qu'inhibiteurs de malt1
MA55194A (fr) Composés hétérocycliques en tant qu'immunomodulateurs
MA46981A (fr) Dérivés de benzimidazole en tant qu'inhibiteurs de bromodomaine
IL268852A (en) Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan
EP3402787A4 (en) PROCESSES FOR PREPARING 2,5-FURANDICARBOXYLIC ACID AND INTERMEDIATES AND DERIVATIVES THEREOF
MA41140A (fr) Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg
MA40774A (fr) Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38
EP2989106A4 (en) CONDENSED HETEROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS
IL292161A (en) New methylquinazolinone derivatives
DK3497081T3 (da) Fremgangsmåde til fremstilling af 4-ammonium-2,2,6,6-tetraalkylpiperidinylsalte
MA42592A (fr) Utilisation de dérivés de 2-(pyrazolopyridin-3-yl) pyrimidine en tant qu'inhibiteurs de jak
DK3601225T3 (da) Substituerede indolinderivater som inhibitorer af denguevirus-replikation
ME03723B (me) 2-amin0-6-(difluorometil)- 5,5-difluoro-6-fenil-3,4,5,6-tetrahidropiridini kао васе1 inhibiтori
EP3807279A4 (en) Pharmaceutically acceptable salts of sepiapterin
EP3318580A4 (en) AQUEOUS EMULSION COMPOSITION
MA47736A (fr) Pyrimidopyrimidinones utiles en tant qu'inhibiteurs de la kinase wee-1
DK3279202T3 (da) Krystal af 3,5-disubstitueret benzenalkynylforbindelse
EP3418275A4 (en) Novel 2,3,5-substituted thiophene compound as protein kinase inhibitor
DK3390407T3 (da) Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
DK3390412T3 (da) Vandopløselige derivater af 3,5-diphenyl-diazolforbindelser
DK3277287T3 (da) Blandinger af humane mælke-oligosaccharider, der omfatter 3 '-o-sialyllactose
DK3823971T3 (da) Substituerede triazol-quinoxalin-derivater
EP2976338A4 (en) N- (2-CYANO-HETEROCYCLYL) PYRAZOLPYRIDONE AS JANUSKINASEINHIBITORS
DK3619199T3 (da) Fremstilling af 2-([1,2,3]triazol-2-yl)-benzoesyrederivater
DK3826723T3 (da) Boronsyrederivater